These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10051823)

  • 21. A short-term, multicenter, randomized double-blind dose titration study of the efficacy and anticholinergic side effects of transdermal compared to immediate release oral oxybutynin treatment of patients with urge urinary incontinence.
    Davila GW; Daugherty CA; Sanders SW;
    J Urol; 2001 Jul; 166(1):140-5. PubMed ID: 11435842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of detrusor instability with oxybutynin rectal suppositories.
    Winkler HA; Sand PK
    Int Urogynecol J Pelvic Floor Dysfunct; 1998; 9(2):100-2. PubMed ID: 9694139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of oxybutynin hydrochloride in the treatment of enuresis nocturna--a clinical and urodynamic study.
    Koşar A; Arikan N; Dinçel C
    Scand J Urol Nephrol; 1999 Apr; 33(2):115-8. PubMed ID: 10360452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical evaluation of terodiline hydrochloride in patients with urinary frequency or incontinence].
    Yasuno H; Ogawa T; Arakawa S; Matsumoto O; Kamidono S; Kataoka N; Matsushita M; Inaba Y; Umezu K; Yamashita M
    Hinyokika Kiyo; 1991 Apr; 37(4):431-9. PubMed ID: 1892003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticholinergics do not improve cure rate of alarm treatment of monosymptomatic nocturnal enuresis.
    Yucel S; Kol A; Guntekin E; Baykara M
    Urology; 2011 Mar; 77(3):721-4. PubMed ID: 21215431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neuropsychiatric adverse effects attributed to use of oxybutynin].
    t'Veld BA; Kwee-Zuiderwijk WJ; van Puijenbroek EP; Stricker BH
    Ned Tijdschr Geneeskd; 1998 Mar; 142(11):590-2. PubMed ID: 9623118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Outpatient urodynamic monitoring in the diagnosis of subclinical forms of a urination disorder in women].
    Bernikov AN; Pushkar' DIu; Loran OB
    Urol Nefrol (Mosk); 1997; (3):31-4. PubMed ID: 9245054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transient bilateral blindness and posterior reversible encephalopathy syndrome: a rare complication of enuresis treatment.
    Branson JA; Dale RC
    J Paediatr Child Health; 2008 Jun; 44(6):380-2. PubMed ID: 18476934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Propiverine compared to oxybutynin in neurogenic detrusor overactivity--results of a randomized, double-blind, multicenter clinical study.
    Stöhrer M; Mürtz G; Kramer G; Schnabel F; Arnold EP; Wyndaele JJ;
    Eur Urol; 2007 Jan; 51(1):235-42. PubMed ID: 16698176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Enuresis and benign micturition disorders in childhood. I. Diagnosis and management].
    Cochat P; Meunier P; Di Maio M
    Arch Pediatr; 1995 Jan; 2(1):57-64. PubMed ID: 7735428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Changes in lower urinary tract function in children with hyperactive urinary bladder treated with combined therapy].
    Danilova TI; Medvedeva EV; Vasil'eva ZhB; Danilov VV
    Urologiia; 2007; (3):77-81. PubMed ID: 17722623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.
    Schmid DM; Sauermann P; Werner M; Schuessler B; Blick N; Muentener M; Strebel RT; Perucchini D; Scheiner D; Schaer G; John H; Reitz A; Hauri D; Schurch B
    J Urol; 2006 Jul; 176(1):177-85. PubMed ID: 16753396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Which stop test is best? Measuring detrusor contractility in older females.
    Tan TL; Bergmann MA; Griffiths D; Resnick NM
    J Urol; 2003 Mar; 169(3):1023-7. PubMed ID: 12576837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electromotive drug-administration: a pilot study for minimal-invasive treatment of therapy-resistant idiopathic detrusor overactivity.
    Bach P; Wormland RT; Möhring C; Goepel M
    Neurourol Urodyn; 2009; 28(3):209-13. PubMed ID: 19205067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Surgery (TUR-P) as a recommended initial treatment modality for the presented case].
    Gotoh M
    Hinyokika Kiyo; 2005 Sep; 51(9):603-8. PubMed ID: 16229373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The elderly patient with urge incontinence or urge-stress incontinence - efficacy and cardiac safety of propiverine].
    Dorschner W; Stolzenburg JU; Griebenow R; Halaska M; Brünjes R; Frank M; Wieners F
    Aktuelle Urol; 2003 Mar; 34(2):102-8. PubMed ID: 14566693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxybutynin hydrochloride (3 mg) in the treatment of women with idiopathic detrusor instability.
    Moore KH; Hay DM; Imrie AE; Watson A; Goldstein M
    Br J Urol; 1990 Nov; 66(5):479-85. PubMed ID: 2249115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tropacin in the treatment of patients with the hyperactive urinary bladder].
    Krivoborodov GG; Shvarts PG
    Ter Arkh; 2001; 73(10):55-8. PubMed ID: 11763519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic treatment for nocturnal urinary frequency following a sleep-micturition chart.
    Yamao Y; Kawauchi A; Tanaka Y; Watanabe H; Kitamori T; Imada N; Shirakawa S
    Psychiatry Clin Neurosci; 1999 Apr; 53(2):277-8. PubMed ID: 10459711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In overactive bladder, above all urgency is stressful. The patients know the site of each toilet].
    MMW Fortschr Med; 2004 May; 146(22):51. PubMed ID: 15373116
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.